Question 1

How many shares of CPRX does Wealthspire Advisors, LLC own?

Accepted Answer

As of 2026-Q2, Wealthspire Advisors, LLC holds 18,142 shares of CPRX (CATALYST PHARMACEUTICALS INC).

Question 2

What is Wealthspire Advisors, LLC's CPRX position worth?

Accepted Answer

As of 2026-Q2, Wealthspire Advisors, LLC's CPRX position is worth $570,204.

Question 3

Is Wealthspire Advisors, LLC buying or selling CPRX?

Accepted Answer

In 2026-Q2, Wealthspire Advisors, LLC decreased their CPRX position (-47.2% change in shares).

Question 4

When did Wealthspire Advisors, LLC first buy CPRX?

Accepted Answer

Based on available 13F filings, Wealthspire Advisors, LLC first reported a position in CPRX in 2024-Q3. They have held the position across 26 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	18,142	-47.2%	$570,204	0.0%	$31.43	0
2026-Q1	Decreased	34,359	-7.5%	$850,729	0.0%	$23.92	0
2025-Q4	Increased	37,160	+0.9%	$867,315	0.0%	$23.29	25
2025-Q3	Decreased	36,843	-0.1%	$725,807	0.0%	$19.55	0
2025-Q2	Increased	36,879	+7.1%	$800,275	0.0%	$21.78	27
2025-Q1	Increased	34,434	+0.2%	$835,025	0.0%	$24.69	25
2024-Q4	Increased	34,355	+0.3%	$716,989	0.0%	$21.07	25
2024-Q3	Decreased	34,271	-5.6%	$681,308	0.0%	$19.56	0